"O CGO é referência em oncologia no estado de Goiás, oferece serviços de atendimento clinico, prevenção, quimioterapia ambulatorial e completo suporte para o paciente durante todo o tratamento, por meio de profissionais especializados em oncologia e nas áreas de farmácia, enfermagem e oncogenética. Além disso, o CGO possui médicos clínicos de renome no tratamento do câncer contando também com plantonistas a disposição em suas unidades para atendimento de emergência. Toda a equipe segue um padrão de tratamento estabelecido, os quais sempre estão disponíveis para discussão de casos e outras orientações eventualmente necessárias para asseguramos um tratamento uniforme de alto nível a todos os pacientes atendidos."

During the past decade, Centro Goiano de Oncologia - CGO conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Goiano de Oncologia - CGO" #1 sponsor was "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 1 trials, followed by "Genentech, Inc." with 1 trials sponsored, "Genmab" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "NSABP Foundation Inc" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Goiano de Oncologia - CGO" #1 collaborator was "Hoffmann-La Roche" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Cancer International Research Group (CIRG)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Centro Goiano de Oncologia - CGO" are "B-cell Lymphoma" (1 trials), "Breast Cancer" (1 trials), "Diffuse Large B-Cell Lymphoma (DLBCL)" (1 trials), "Follicular NHL Grade 3b" (1 trials) and "Head and Neck Cancer" (1 trials). Many other conditions were trialed in "Centro Goiano de Oncologia - CGO" in a lesser frequency.

Most popular intervention types in "Centro Goiano de Oncologia - CGO" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Docetaxel" (2 trials), "Placebo" (2 trials), "Rituximab" (2 trials) and "Trastuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centro Goiano de Oncologia - CGO" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centro Goiano de Oncologia - CGO". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Centro Goiano de Oncologia - CGO, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Goiano de Oncologia - CGO, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".